BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11168293)

  • 1. Effect of somatostatin on postprandial gallbladder relaxation.
    Vu MK; Van Oostayen JA; Biemond I; Masclee AA
    Clin Physiol; 2001 Jan; 21(1):25-31. PubMed ID: 11168293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction.
    Glasbrenner B; Domínguez-Muñoz JE; Nelson DK; Pieramico O; Holzwarth C; Riepl RL; Malfertheiner P
    Am J Gastroenterol; 1994 Mar; 89(3):404-10. PubMed ID: 8122654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rectal distension on gallbladder emptying and circulating gut hormones.
    van Hoek F; Mollen RM; Hopman WP; Kuijpers HH; Jansen JB
    Eur J Clin Invest; 2000 Nov; 30(11):988-94. PubMed ID: 11114961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of circulating peptide YY on gallbladder emptying in humans.
    Hoentjen F; Hopman WP; Jansen JB
    Scand J Gastroenterol; 2001 Oct; 36(10):1086-91. PubMed ID: 11589384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent inhibition of postprandial gallbladder motility and plasma hormone secretion during acute hyperglycemia.
    Gielkens HA; van Oostayen JA; Frölich M; Biemond I; Lamers CB; Masclee AA
    Scand J Gastroenterol; 1998 Oct; 33(10):1074-9. PubMed ID: 9829363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallbladder dynamics in chronic pancreatitis. Relationship to exocrine pancreatic function, CCK, and PP release.
    Glasbrenner B; Malfertheiner P; Pieramico O; Klatt S; Riepl R; Friess H; Ditschuneit H
    Dig Dis Sci; 1993 Mar; 38(3):482-9. PubMed ID: 8444080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallbladder motility in Crohn disease: influence of disease localization and bowel resection.
    Vu MK; Gielkens HA; van Hogezand RA; van Oostayen JA; Lamers CB; Masclee AA
    Scand J Gastroenterol; 2000 Nov; 35(11):1157-62. PubMed ID: 11145286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons.
    Di Francesco V; Zamboni M; Dioli A; Zoico E; Mazzali G; Omizzolo F; Bissoli L; Solerte SB; Benini L; Bosello O
    J Gerontol A Biol Sci Med Sci; 2005 Dec; 60(12):1581-5. PubMed ID: 16424292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallbladder motility and cholecystokinin secretion in chronic pancreatitis: relationship with exocrine pancreatic function.
    Gielkens HA; Eddes EH; Vecht J; van Oostayen JA; Lamers CB; Masclee AA
    J Hepatol; 1997 Aug; 27(2):306-12. PubMed ID: 9288605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial gallbladder motility and plasma cholecystokinin at regular time intervals after injection of octreotide in acromegalics on long-term treatment.
    Hopman WP; Van Liessum PA; Pieters GF; Jansen JB; Lamers CB; Smals AG; Rosenbusch G; Kloppenborg PW
    Dig Dis Sci; 1992 Nov; 37(11):1685-90. PubMed ID: 1425066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial gut peptide plasma levels in women with idiopathic slow-transit constipation.
    Peracchi M; Basilisco G; Tagliabue R; Terrani C; Locati A; Bianchi PA; Velio P
    Scand J Gastroenterol; 1999 Jan; 34(1):25-8. PubMed ID: 10048728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallbladder emptying and cholecystokinin and pancreatic polypeptide responses to a liquid meal in patients with diabetes mellitus.
    Meguro T; Shimosegawa T; Satoh A; Suzuki H; Takasu A; Takayama A; Koizumi M; Toyota T
    J Gastroenterol; 1997 Oct; 32(5):628-34. PubMed ID: 9349988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.
    Ellrichmann M; Kapelle M; Ritter PR; Holst JJ; Herzig KH; Schmidt WE; Schmitz F; Meier JJ
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3995-8. PubMed ID: 18647814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of neurotensin in human gallbladder motility.
    Walker JP; Khalil T; Wiener I; Fagan CJ; Townsend CM; Greeley GH; Thompson JC
    Ann Surg; 1985 Jun; 201(6):678-83. PubMed ID: 3890780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of gallbladder contraction by pirenzepine in humans.
    Yeğen B; Biren T; Onat F; Tankurt E; Gürmen N; Oktay S; Chey WY; Ulusoy NB
    Am J Gastroenterol; 1995 Sep; 90(9):1489-94. PubMed ID: 7661176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous infusion of amino acids on cholecystokinin release and gallbladder contraction in humans.
    Shirohara H; Tabaru A; Otsuki M
    J Gastroenterol; 1996 Aug; 31(4):572-7. PubMed ID: 8844480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial gall bladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly.
    Stolk MF; van Erpecum KJ; Koppeschaar HP; de Bruin WI; Jansen JB; Lamers CB; van Berge Henegouwen GP
    Gut; 1993 Jun; 34(6):808-13. PubMed ID: 8314514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study.
    Froehlich F; Hartmann D; Guezelhan C; Gonvers JJ; Jansen JB; Fried M
    Dig Dis Sci; 1996 Dec; 41(12):2404-8. PubMed ID: 9011450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nutrient fat and cholecystokinin in regulation of gallbladder emptying in man.
    Froehlich F; Gonvers JJ; Fried M
    Dig Dis Sci; 1995 Mar; 40(3):529-33. PubMed ID: 7895538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of vapreotide, a somatostatin analogue, on gastric acidity, gallbladder emptying and hormone release after 1 week of continuous subcutaneous infusion in normal subjects.
    Ritz MA; Drewe J; Ziel A; Hildebrand P; Schneider P; Lahlou N; Beglinger C
    Br J Clin Pharmacol; 1999 Feb; 47(2):195-201. PubMed ID: 10190655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.